CDK2 and sarcoma: Consistent with these findings, we identified a molecular dependence on the CCNE/CDK2 complex in CIC::DUX4 sarcoma, whereby CIC::DUX4 acts as a transcriptional activator to upregulate CCNE1 to drive sarcoma growth and survival [6].